Authors:
Carrieri, P
Cailleton, V
Le Moing, V
Spire, B
Dellamonica, P
Bouvet, E
Raffi, F
Journot, V
Moatti, JP
Citation: P. Carrieri et al., The dynamic of adherence to highly active antiretroviral therapy: Results from the French National APROCO cohort, J ACQ IMM D, 28(3), 2001, pp. 232-239
Authors:
Le Moing, V
Chene, G
Carrieri, MP
Besnier, JM
Masquelier, B
Salamon, R
Bazin, C
Moatti, JP
Raffi, F
Leport, C
Citation: V. Le Moing et al., Clinical, biologic, and behavioral predictors of early immunologic and virologic response in HIV-infected patients initiating protease inhibitors, J ACQ IMM D, 27(4), 2001, pp. 372-376
Authors:
Abgrall, S
Matheron, S
Le Moing, V
Dupont, C
Costagliola, D
Citation: S. Abgrall et al., Pneumocystis carinii pneumonia recurrence in HIV patients on highly activeantiretroviral therapy: Secondary prophylaxis, J ACQ IMM D, 26(2), 2001, pp. 151-158
Authors:
Duval, X
Trad, S
Le Moing, V
Longuet, P
Leport, C
Vilde, JL
Citation: X. Duval et al., Paradoxical aggravation of tuberculosis after antiretroviral treatment in HIV-infected patients, PRESSE MED, 30(5), 2001, pp. 213-216
Authors:
Di Martino, V
Rufat, P
Boyer, N
Renard, P
Degos, F
Martinot-Peignoux, M
Matheron, S
Le Moing, V
Vachon, F
Degott, C
Valla, D
Marcellin, P
Citation: V. Di Martino et al., The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study, HEPATOLOGY, 34(6), 2001, pp. 1193-1199
Authors:
Le Moing, V
Eid, Z
Ecobichon, JL
Duval, X
Longuet, P
Elbim, C
Brun-Vezinet, F
Leport, C
Vilde, JL
Citation: V. Le Moing et al., Long-term immunologic response in HIV-infected patients with CD4 cell counts <= 50/mm(3) when initiating protease inhibitor therapy., ANN MED IN, 152(1), 2001, pp. 11-14
Authors:
Le Moing, V
Chene, G
Masquelier, B
Sicard, D
Brun-Vezinet, F
Reynes, J
Raffi, F
Citation: V. Le Moing et al., Definition of virologic response and the type of assay used for quantification of viral load may influence the proportion of responders to antiretroviral therapy, J ACQ IMM D, 24(1), 2000, pp. 82-83
Authors:
Duval, X
Le Moing, V
Longuet, P
Leport, C
Vilde, JL
Lamotte, C
Peytavin, G
Farinotti, R
Citation: X. Duval et al., Efavirenz induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir, ANTIM AG CH, 44(9), 2000, pp. 2593-2593
Authors:
Saves, M
Raffi, F
Clevenbergh, P
Marchou, B
Waldner-Combernoux, A
Morlat, P
Le Moing, V
Riviere, C
Chene, G
Leport, C
Citation: M. Saves et al., Hepatitis B or hepatitis C virus infection is a risk factor for severe hepatic cytolysis after initiation of a protease inhibitor-containing antiretroviral regimen in human immunodeficiency virus-infected patients, ANTIM AG CH, 44(12), 2000, pp. 3451-3455
Authors:
Grabar, S
Le Moing, V
Goujard, C
Leport, C
Kazatchkine, MD
Costagliola, D
Weiss, L
Citation: S. Grabar et al., Clinical outcome of patients with HIV-1 infection according to immunologicand virologic response after 6 months of highly active antiretroviral therapy, ANN INT MED, 133(6), 2000, pp. 401-410
Authors:
Le Moing, V
Lacassin, F
Delahousse, M
Duval, X
Longuet, P
Leport, C
Vilde, JL
Citation: V. Le Moing et al., Use of corticosteroids in glomerulonephritis related to infective endocarditis: Three cases and review, CLIN INF D, 28(5), 1999, pp. 1057-1061
Authors:
Benveniste, O
Longuet, P
Duval, X
Le Moing, V
Leport, C
Vilde, JL
Citation: O. Benveniste et al., Two episodes of acute renal failure, rhabdomyolysis, and severe hepatitis in an AIDS patient successively treated with ritonavir and indinavir, CLIN INF D, 28(5), 1999, pp. 1180-1181
Authors:
Longuet, P
Duval, X
Le Moing, V
Scanvic-Hameg, A
Leport, C
Vilde, JL
Citation: P. Longuet et al., Antibiotic prophylaxis in patients at risk of a nosocomial outbreak of legionnellosis, PRESSE MED, 28(32), 1999, pp. 1755-1756
Authors:
Le Moing, V
Geniteau, M
Lacassin, F
Nicaise, P
Leport, C
Labarre, C
Vilde, JL
Citation: V. Le Moing et al., Imbalance of immunoglobulin G subclasses in HIV-infected patients with pneumococcal infection., MED MAL INF, 29(10), 1999, pp. 613-618